Trends in prostate specific antigen testing in Ireland: lessons from a country without guidelines
Trends in prostate specific antigen testing in Ireland: lessons from a country without guidelines
复制标题
DOI：
10.1007/s11845-009-0376-7
复制
发表时间：
2010-03-01
影响因子：
2.1
通讯作者：
Comber, H.
中科院分区：
文献类型：
--
作者：
Drummond, F. J.;Carsin, A. -E.;Comber, H.
背景前列腺特异性抗原（PSA）检测与前列腺癌（PCa）发病率增加相关。爱尔兰没有关于前列腺癌筛查的国家指南，2006年，爱尔兰前列腺癌发病率在欧洲最高。目的：研究爱尔兰PSA检测的趋势。方法：收集1994-2005年PSA检测的数据。结果：50岁以下男性PSA检测的标准化率每年分别增加39%和25%。大多数测试在50-69岁的男性中进行;分别有26%和22%在≥ 70岁的男性中进行。基线PSA测试在2004年达到峰值，男性为16%。83%的基线测试结果
Background Prostate specific antigen (PSA) testing is associated with increased prostate cancer (PCa) incidence. Ireland has no national guidelines on PCa screening and had the highest PCa incidence in Europe, 2006.Aims To investigate trends in PSA testing in Ireland.Methods Data on PSA tests, 1994-2005, was collated.Results Age-standardised rates of PSA testing increased 39 and 25% annually in men = 50 years, respectively. Most tests were performed in men 50-69 years; 26 and 22% were performed in men = 70 years, respectively. Baseline PSA tests peaked in 2004, at 16% of men. 83% of baseline tests were